5-Oxoprolinase levels were higher in ovarian cancer, more prevalent in tumor cells like bladder and nasopharyngeal cancer, and unaffected in colon cancer, indicating possible drawbacks of all-encompassing strategy. This evidence concerns the gene OPLAH and ovarian carcinoma.